PUI
BEAM icon

Purpose Unlimited Inc’s Beam Therapeutics BEAM Stock Holding History

Purpose Unlimited Inc’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105K Buy
+3,049
New +$92.1K ﹤0.01% 291
2026
Q1 		– Sell
-2,894
Closed -$80.2K – 584
2025
Q4 		$80.2K Buy
+2,894
New +$73.8K ﹤0.01% 224

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Purpose Unlimited Inc's BEAM Position: Q2 2026 in Review

Purpose Unlimited Inc opened a new position in Beam Therapeutics (BEAM) in Q2 2026: 3,049 shares worth $105K. The stake represents ﹤0.01% of the portfolio and ranks #291 among its holdings. This is a return to the name: Purpose Unlimited Inc previously reported a position in BEAM as recently as Q4 2025.

Purpose Unlimited Inc first reported a position in BEAM in Q4 2025 and has held it in 2 quarters since. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Purpose Unlimited Inc held 3,049 shares of Beam Therapeutics worth $105K as of Q2 2026.
  • Beam Therapeutics was a new Purpose Unlimited Inc position in Q2 2026.
  • Beam Therapeutics made up ﹤0.01% of Purpose Unlimited Inc's portfolio in Q2 2026, its #291 holding.
  • Purpose Unlimited Inc first reported a position in Beam Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Purpose Unlimited Inc's 13F filing for Q2 2026, filed 13 Aug 2026.